INTRODUCTION
Aging skin is characterized by dermal thinning with collagen, elastin loss, and altered fat volume and distribution.1,2 These changes occur due to the degradation of the skin's structural components with function alteration due to intrinsic and extrinsic factors.3,4
The epidermis and dermis atrophy are due to decreased and inefficient mast cells and fibroblasts, which are key to structural alterations, including diminished collagen, proteoglycans, and elastin.3,4 Senescent fibroblasts create a pro-aging microenvironment.5 In pro-aging environments, matrix metalloproteinases (MMPs) are activated, accelerating extracellular matrix (ECM) breakdown and suppressing growth factor release.3 In addition, complex negative feedback loops occur due to abnormal collagen and elastin metabolism, increasing MMPs and furthering ECM degradation.3,6 Superficial and deep facial fat compartments are also altered.7 Fat can reposition, which is most apparent in the jowl, lateral nasolabial fold (NLF), and labiomental crease.7
When selecting treatments, it is important to consider regeneration. Regenerative pathways activate multiple systems that help restore the tissue's natural architecture and function. Treatments that offer tissue replacement primarily result in connective tissue deposition, which does not translate to natural morphology or function.3 Regenerative aesthetics focuses on the recreation of normal/youthful functioning tissue.3 An important step toward regenerative aesthetics approaches includes identifying potentially regenerative treatments.3 Regenerative approaches use cells, bio-cues, and scaffolds.3 Scaffolds may be regenerative or non-regenerative. Regenerative scaffolding can stimulate structural tissue components, while non-regenerative scaffolds lead to narrow tissue-type formation.3
Poly-L-lactic acid (PLLA) and calcium hydroxylapatite (CaHA) are both commonly used aesthetic treatments.4 Soft-tissue injectables are popular because they are minimally invasive and are effective for restoring volume and correcting contour deficiencies.8 PLLA-SCATM (Sculptra®, Galderma Laboratories,